140 related articles for article (PubMed ID: 26079089)
1. TRPV1 modulators: Synthesis and in vitro evaluation of 1-heteroaryl piperidinecarboxamide and piperazinylurea derivatives.
Congiu C; Onnis V; Balboni G; Schiano-Moriello A; Di Marzo V; De Petrocellis L
Eur J Med Chem; 2015 Jul; 100():129-38. PubMed ID: 26079089
[TBL] [Abstract][Full Text] [Related]
2. In vitro TRPV1 activity of piperine derived amides.
Correa EA; Högestätt ED; Sterner O; Echeverri F; Zygmunt PM
Bioorg Med Chem; 2010 May; 18(9):3299-306. PubMed ID: 20381363
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of thiazole carboxamides as vanilloid receptor 1 (TRPV1) antagonists.
Xi N; Bo Y; Doherty EM; Fotsch C; Gavva NR; Han N; Hungate RW; Klionsky L; Liu Q; Tamir R; Xu S; Treanor JJ; Norman MH
Bioorg Med Chem Lett; 2005 Dec; 15(23):5211-7. PubMed ID: 16203144
[TBL] [Abstract][Full Text] [Related]
4. Discovery of piperidine carboxamide TRPV1 antagonists.
Cheung WS; Calvo RR; Tounge BA; Zhang SP; Stone DR; Brandt MR; Hutchinson T; Flores CM; Player MR
Bioorg Med Chem Lett; 2008 Aug; 18(16):4569-72. PubMed ID: 18662879
[TBL] [Abstract][Full Text] [Related]
5. Heteroaryl beta-tetralin ureas as novel antagonists of human TRPV1.
Jetter MC; Youngman MA; McNally JJ; McDonnell ME; Zhang SP; Dubin AE; Nasser N; Codd EE; Flores CM; Dax SL
Bioorg Med Chem Lett; 2007 Nov; 17(22):6160-3. PubMed ID: 17892935
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of novel diarylalkyl amides as TRPV1 antagonists.
Li FN; Kim NJ; Paek SM; Kwon DY; Min KH; Jeong YS; Kim SY; Park YH; Kim HD; Park HG; Suh YG
Bioorg Med Chem; 2009 May; 17(10):3557-67. PubMed ID: 19398205
[TBL] [Abstract][Full Text] [Related]
7. From arylureas to biarylamides to aminoquinazolines: discovery of a novel, potent TRPV1 antagonist.
Zheng X; Hodgetts KJ; Brielmann H; Hutchison A; Burkamp F; Brian Jones A; Blurton P; Clarkson R; Chandrasekhar J; Bakthavatchalam R; De Lombaert S; Crandall M; Cortright D; Blum CA
Bioorg Med Chem Lett; 2006 Oct; 16(19):5217-21. PubMed ID: 16870426
[TBL] [Abstract][Full Text] [Related]
8. Fatty acyl amides of endogenous tetrahydroisoquinolines are active at the recombinant human TRPV1 receptor.
O'Dell DK; Rimmerman N; Pickens SR; Walker JM
Bioorg Med Chem; 2007 Sep; 15(18):6164-9. PubMed ID: 17616464
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies of a novel series of isoxazole-3-carboxamide derivatives as TRPV1 antagonists.
Palin R; Abernethy L; Ansari N; Cameron K; Clarkson T; Dempster M; Dunn D; Easson AM; Edwards D; Maclean J; Everett K; Feilden H; Ho KK; Kultgen S; Littlewood P; McArthur D; McGregor D; McLuskey H; Neagu I; Neale S; Nisbet LA; Ohlmeyer M; Pham Q; Ratcliffe P; Rong Y; Roughton A; Sammons M; Swanson R; Tracey H; Walker G
Bioorg Med Chem Lett; 2011 Feb; 21(3):892-8. PubMed ID: 21236666
[TBL] [Abstract][Full Text] [Related]
10. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor.
Gunthorpe MJ; Hannan SL; Smart D; Jerman JC; Arpino S; Smith GD; Brough S; Wright J; Egerton J; Lappin SC; Holland VA; Winborn K; Thompson M; Rami HK; Randall A; Davis JB
J Pharmacol Exp Ther; 2007 Jun; 321(3):1183-92. PubMed ID: 17392405
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of a TRPV1 receptor antagonist.
Yu S; Haight A; Kotecki B; Wang L; Lukin K; Hill DR
J Org Chem; 2009 Dec; 74(24):9539-42. PubMed ID: 19928811
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 2-(3,5-difluoro-4-methylsulfonaminophenyl)propanamides as potent TRPV1 antagonists.
Kim C; Ann J; Lee S; Sun W; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
Bioorg Med Chem Lett; 2018 Aug; 28(14):2539-2542. PubMed ID: 29884534
[TBL] [Abstract][Full Text] [Related]
13. Binding of [(3)H]A-778317 to native transient receptor potential vanilloid-1 (TRPV1) channels in rat dorsal root ganglia and spinal cord.
Bianchi BR; El Kouhen R; Chen J; Puttfarcken PS
Eur J Pharmacol; 2010 May; 633(1-3):15-23. PubMed ID: 20153316
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity studies of a novel series of 5,6-fused heteroaromatic ureas as TRPV1 antagonists.
Drizin I; Gomtsyan A; Bayburt EK; Schmidt RG; Zheng GZ; Perner RJ; DiDomenico S; Koenig JR; Turner SC; Jinkerson TK; Brown BS; Keddy RG; McDonald HA; Honore P; Wismer CT; Marsh KC; Wetter JM; Polakowski JS; Segreti JA; Jarvis MF; Faltynek CR; Lee CH
Bioorg Med Chem; 2006 Jul; 14(14):4740-9. PubMed ID: 16621571
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of novel biphenyl-4-carboxamide derivatives as orally available TRPV1 antagonists.
Oka H; Yonezawa K; Kamikawa A; Ikegai K; Asai N; Shirakami S; Miyamoto S; Watanabe T; Kiso T; Takemoto Y; Tamura S; Kuramochi T
Bioorg Med Chem; 2018 Jul; 26(12):3716-3726. PubMed ID: 29887511
[TBL] [Abstract][Full Text] [Related]
16. Novel piperazine urea derivatives as highly potent transient receptor potential vanilloid 1 (TRPV1) antagonists.
Hu J; Gao M; Zhang Y; Wang Y; Qiao Z; Zhang W; Wang Q; Yan L; Qian H
Bioorg Chem; 2021 Oct; 115():105229. PubMed ID: 34364049
[TBL] [Abstract][Full Text] [Related]
17. Dopamides, vanillylamides, ethanolamides, and arachidonic acid amides of anti-inflammatory and analgesic drug substances as TRPV1 ligands.
Sinning C; Watzer B; De Petrocellis L; Di Marzo V; Imming P
ChemMedChem; 2008 Dec; 3(12):1956-64. PubMed ID: 19003845
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of [6]-gingerol analogues as transient receptor potential channel TRPV1 and TRPA1 modulators.
Morera E; De Petrocellis L; Morera L; Moriello AS; Nalli M; Di Marzo V; Ortar G
Bioorg Med Chem Lett; 2012 Feb; 22(4):1674-7. PubMed ID: 22257892
[TBL] [Abstract][Full Text] [Related]
19. Discovery of (R)-1-(7-chloro-2,2-bis(fluoromethyl)chroman-4-yl)-3-(3-methylisoquinolin-5-yl)urea (A-1165442): a temperature-neutral transient receptor potential vanilloid-1 (TRPV1) antagonist with analgesic efficacy.
Voight EA; Gomtsyan AR; Daanen JF; Perner RJ; Schmidt RG; Bayburt EK; DiDomenico S; McDonald HA; Puttfarcken PS; Chen J; Neelands TR; Bianchi BR; Han P; Reilly RM; Franklin PH; Segreti JA; Nelson RA; Su Z; King AJ; Polakowski JS; Baker SJ; Gauvin DM; Lewis LR; Mikusa JP; Joshi SK; Faltynek CR; Kym PR; Kort ME
J Med Chem; 2014 Sep; 57(17):7412-24. PubMed ID: 25100568
[TBL] [Abstract][Full Text] [Related]
20. 6,6-Fused heterocyclic ureas as highly potent TRPV1 antagonists.
Sun W; Kim HS; Lee S; Jung A; Kim SE; Ann J; Yoon S; Choi S; Lee JH; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Schiene K; Stockhausen H; Christoph T; Frormann S; Lee J
Bioorg Med Chem Lett; 2015 Feb; 25(4):803-6. PubMed ID: 25597011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
